It also plays a significant role in LUAD, where its inhibition may suppress tumor growth and metastasis.[30,31] GREM1 deregulation in COPD contributes to a pro-fibrotic, pro-inflammatory environment that may promote lung cancer development. This evidence concerns the gene GREM1 and lung carcinoma.